EPS for Summit Therapeutics plc (SMMT) Expected At $-0.76; Dominos Pizza (DPZ)’s Sentiment Is 0.91

May 21, 2018 - By William Brooks

Summit Therapeutics plc (NASDAQ:SMMT) Logo

Analysts expect Summit Therapeutics plc (NASDAQ:SMMT) to report $-0.76 EPS on June, 13.They anticipate $0.26 EPS change or 52.00% from last quarter’s $-0.5 EPS. After having $-1.15 EPS previously, Summit Therapeutics plc’s analysts see -33.91% EPS growth. The stock increased 0.93% or $0.13 during the last trading session, reaching $14.09. About 46,400 shares traded or 20.01% up from the average. Summit Therapeutics plc (NASDAQ:SMMT) has risen 4.52% since May 21, 2017 and is uptrending. It has underperformed by 7.03% the S&P500.

Dominos Pizza Inc (DPZ) investors sentiment decreased to 0.91 in 2017 Q4. It’s down -0.24, from 1.15 in 2017Q3. The ratio turned negative, as 153 institutional investors started new and increased positions, while 168 sold and reduced positions in Dominos Pizza Inc. The institutional investors in our database now own: 42.61 million shares, down from 42.77 million shares in 2017Q3. Also, the number of institutional investors holding Dominos Pizza Inc in top ten positions increased from 3 to 5 for an increase of 2. Sold All: 45 Reduced: 123 Increased: 91 New Position: 62.

More important recent Domino's Pizza, Inc. (NYSE:DPZ) news were published by: Nasdaq.com which released: “3 Stocks That Could Have Doubled Your Money” on May 18, 2018, also Streetinsider.com published article titled: “Tiger Global’s 13F Shows New Stake in Twitter (TWTR), Mercado (MELI), Increases Stake in Amazon (AMZN) (more…)”, Nasdaq.com published: “Here’s Why Domino’s Thinks Its Growth Story Is Just Getting Started” on May 12, 2018. More interesting news about Domino's Pizza, Inc. (NYSE:DPZ) was released by: Benzinga.com and their article: “The Week Ahead: Sohn Conference, FANG Earnings, DocuSign IPO” with publication date: April 23, 2018.

Ratings analysis reveals 67% of Domino’s Pizza’s analysts are positive. Out of 3 Wall Street analysts rating Domino’s Pizza, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $158.0 while the high is $175.0. The stock’s average target of $166.50 is -32.00% below today’s ($244.86) share price. DPZ was included in 3 notes of analysts from October 4, 2016. Maxim Group maintained the stock with “Hold” rating in Tuesday, October 4 report. Bank of America upgraded Domino's Pizza, Inc. (NYSE:DPZ) on Friday, October 14 to “Buy” rating. The rating was upgraded by KeyBanc Capital Markets to “Overweight” on Friday, January 20.

DominoÂ’s Pizza, Inc., through its subsidiaries, operates as a pizza delivery firm in the United States and internationally. The company has market cap of $10.35 billion. It operates through three divisions: Domestic Stores, Supply Chain, and International Franchise. It has a 42 P/E ratio. The firm offers pizzas under the DominoÂ’s Pizza brand name through company-owned and franchised DominoÂ’s Pizza stores.

Crestwood Capital Management L.P. holds 5.49% of its portfolio in Domino's Pizza, Inc. for 55,080 shares. Dock Street Asset Management Inc owns 44,442 shares or 3.25% of their US portfolio. Moreover, Tiger Global Management Llc has 3.1% invested in the company for 2.08 million shares. The New York-based Antipodean Advisors Llc has invested 3.07% in the stock. Incline Global Management Llc, a New York-based fund reported 253,944 shares.

The stock decreased 0.69% or $1.69 during the last trading session, reaching $244.86. About 697,857 shares traded. Domino's Pizza, Inc. (DPZ) has risen 25.89% since May 21, 2017 and is uptrending. It has outperformed by 14.34% the S&P500.

Analysts await Domino's Pizza, Inc. (NYSE:DPZ) to report earnings on July, 24. They expect $1.72 earnings per share, up 30.30% or $0.40 from last year’s $1.32 per share. DPZ’s profit will be $72.72M for 35.59 P/E if the $1.72 EPS becomes a reality. After $2.00 actual earnings per share reported by Domino's Pizza, Inc. for the previous quarter, Wall Street now forecasts -14.00% negative EPS growth.

Since January 1, 0001, it had 0 buys, and 3 selling transactions for $18.90 million activity.

Among 10 analysts covering Summit Therapeutic (NASDAQ:SMMT), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Summit Therapeutic had 18 analyst reports since August 19, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, April 11 by Canaccord Genuity. SunTrust maintained the shares of SMMT in report on Friday, April 13 with “Buy” rating. Oppenheimer maintained the shares of SMMT in report on Wednesday, August 19 with “Buy” rating. The firm earned “Buy” rating on Thursday, July 6 by H.C. Wainwright. As per Friday, December 1, the company rating was reinitiated by H.C. Wainwright. On Thursday, June 22 the stock rating was maintained by Oppenheimer with “Buy”. Canaccord Genuity maintained Summit Therapeutics plc (NASDAQ:SMMT) on Tuesday, March 6 with “Buy” rating. The firm earned “Hold” rating on Tuesday, September 1 by Zacks. The stock has “Buy” rating by H.C. Wainwright on Friday, September 16. As per Thursday, June 15, the company rating was maintained by Canaccord Genuity.

More notable recent Summit Therapeutics plc (NASDAQ:SMMT) news were published by: Globenewswire.com which released: “Summit Therapeutics plc : Notice of AGM” on May 03, 2018, also Globenewswire.com with their article: “Summit Therapeutics plc : Director/PDMR Shareholding” published on April 23, 2018, Globenewswire.com published: “Award of Share Options and Restricted Stock Units” on April 23, 2018. More interesting news about Summit Therapeutics plc (NASDAQ:SMMT) were released by: Benzinga.com and their article: “Summit Therapeutics’ Upcoming Duchenne Muscular Dystrophy Data ‘A Strong Catalyst,’ Janney Says In Bullish Initiation” published on May 05, 2018 as well as Nasdaq.com‘s news article titled: “Summit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late …” with publication date: April 23, 2018.

Domino's Pizza, Inc. (NYSE:DPZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 William Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts